Kezar Life Sciences logo
Kezar Life Sciences KZR
$ 7.54 0.6%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Kezar Life Sciences Income Statement 2011-2024 | KZR

Annual Income Statement Kezar Life Sciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

61.7 M 348 M 783 M 241 M 52.9 M 177 M - 3.66 M - - - - -

Shares

72.6 M 67.4 M 52.8 M 44 M 19.1 M 10.3 M - 18.3 M - - - - -

Historical Prices

0.85 5.16 14.8 5.48 4.38 20.4 - - - - - - -

Net Income

-102 M -68.2 M -54.6 M -41.7 M -35.1 M -23.2 M -8.52 M -8.99 M - - - - -

Revenue

7 M - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-111 M -71.2 M -54.7 M -43 M -37.3 M -24.7 M -8.75 M -8.99 M - - - - -

Interest Expense

1.55 M 1.18 M 159 K - - - - - - - - - -

EBITDA

-110 M -70.1 M -53.1 M -41.4 M -36 M -24 M -8.57 M -8.84 M - - - - -

Operating Expenses

118 M 71.2 M 54.7 M 43 M 37.3 M 24.7 M - - - - - - -

General and Administrative Expenses

26.5 M 20.2 M 15.7 M 12 M 9.98 M 6.59 M 2.28 M 1.62 M - - - - -

All numbers in USD currency

Quarterly Income Statement Kezar Life Sciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

7.3 M 72.8 M 72.8 M 7.28 M 7.27 M 72.5 M 72.3 M 68.5 M 72.2 M 64.3 M 60.6 M 56.3 M 52 M 51.9 M 51.1 M 46.4 M 50 M 42.9 M 32.9 M 19.2 M 19.1 M 19.1 M 19 M 19.1 M 19 M 2.04 M 757 K 949 K 628 K 569 K - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-20.3 M -21.5 M -21.7 M - -23.1 M -24.3 M -22.2 M - -17.8 M -16.2 M -16 M - -14.5 M -13 M -13 M -10.9 M -11.3 M -9.5 M -10 M -9.58 M -9.15 M -8.72 M -7.64 M -5.78 M -5.66 M -6.78 M -4.95 M -2.3 M -2.08 M -1.88 M -2.26 M - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - 7 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-21.9 M -23.4 M -23.7 M - -25.5 M -26.8 M -24.5 M - -18.9 M -16.3 M -15.9 M - -14.5 M -13 M -13 M - -11.6 M -9.85 M -10.5 M - -9.68 M -9.36 M -8.31 M - -6.26 M -6.95 M -5.09 M - -2.19 M -1.88 M - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

403 K 401 K 400 K - 396 K 385 K 370 K - 310 K 272 K 254 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-21.6 M -23.1 M -23.5 M - -25.2 M -26.6 M -24.3 M - -18.6 M -16.1 M -15.5 M - -13.4 M -12.3 M -12.7 M - -10.4 M -9.12 M -10.1 M - -8.72 M -8.73 M -8.01 M - -5.78 M -6.67 M -5 M - -2.06 M -1.79 M - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

21.9 M 23.4 M 23.7 M - 32.5 M 26.8 M 24.5 M - 18.9 M 16.3 M 15.9 M - 14.5 M 13 M 13 M 11.1 M 11.6 M 9.85 M 10.5 M 10 M 9.68 M 9.36 M 8.31 M 6.43 M 6.26 M 6.95 M 5.09 M 2.42 M 2.19 M 1.88 M 2.26 M - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

5.71 M 5.6 M 6.54 M - 8.79 M 5.78 M 6.21 M - 5.07 M 4.98 M 4.93 M - 3.97 M 3.67 M 3.76 M - 3.29 M 2.7 M 3.02 M - 2.6 M 2.43 M 2.38 M - 1.6 M 1.72 M 1.51 M - 635 K 436 K - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency